Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Market Cap	145.42M -1.9%
Revenue (ttm)	223.68M +5.8%
Net Income	14.16M +15.1%
EPS	0.05 +15.4%
Shares Out	222.01M
PE Ratio	13.91
Forward PE	n/a
Dividend	0.03 (3.82%)
Ex-Dividend Date	Jun 25, 2026

Volume	6,000
Average Volume	32,125
Open	0.6550
Previous Close	0.6800
Day's Range	0.6550 - 0.6550
52-Week Range	0.6050 - 0.7350
Beta	0.14
RSI	49.54
Earnings Date	May 13, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 205
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: RHONEMA

Financial Performance

In 2025, Rhone Ma Holdings Berhad's revenue was 223.68 million, an increase of 5.81% compared to the previous year's 211.41 million. Earnings were 14.16 million, an increase of 15.07%.